Parecoxib Sodium
ApprovedCompleted 1 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Post-Operative Pain
Conditions
Post-Operative Pain
Trial Timeline
Nov 1, 2010 → Sep 1, 2011
NCT ID
NCT01186159About Parecoxib Sodium
Parecoxib Sodium is a approved stage product being developed by Pfizer for Post-Operative Pain. The current trial status is completed. This product is registered under clinical trial identifier NCT01186159. Target conditions include Post-Operative Pain.
What happened to similar drugs?
3 of 11 similar drugs in Post-Operative Pain were approved
Approved (3) Terminated (0) Active (8)
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00435747 | Approved | Withdrawn |
| NCT01186159 | Approved | Completed |
Competing Products
18 competing products in Post-Operative Pain